Lansoprazol Zentiva

Lansoprazole, the active ingredient in Lansoprazol Zentiva, is a proton pump inhibitor presented as an oral dosage form for oral use. It reduces gastric acid secretion and is used to treat acid‑related disorders such as gastro‑oesophageal reflux disease, erosive esophagitis, peptic ulcer disease and Zollinger‑Ellison syndrome.

GNH USA supplies Lansoprazol Zentiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, transplant centres and clinics worldwide.

Lansoprazole is indicated for several acid‑related conditions, acting to suppress gastric acid production.

- Gastro‑oesophageal reflux disease (GERD): reduces esophageal acid exposure and promotes healing of mucosal injury. - Erosive esophagitis: facilitates ulcer healing by maintaining a higher gastric pH. - Peptic ulcer disease: supports ulcer resolution by decreasing gastric acidity. - Helicobacter pylori eradication regimens: enhances the effectiveness of antibiotic combinations by creating a less acidic environment. - Zollinger‑Ellison syndrome: controls hyper‑secretion of gastric acid in this rare neuroendocrine tumor.

Lansoprazole may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Headache: mild, transient headache. - Diarrhea: loose stools, usually self‑limiting. - Nausea: occasional feeling of queasiness. - Abdominal pain: mild discomfort in the stomach area. - Flatulence: increased gas production. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reactions: rash, swelling, difficulty breathing. - Clostridioides difficile infection: severe colitis with diarrhea. - Liver enzyme elevation: signs of hepatic injury. - Low magnesium levels: muscle cramps, irregular heartbeat. - Stevens‑Johnson syndrome: serious skin blistering. - Interstitial nephritis: kidney inflammation.

Before prescribing Lansoprazole, consider the following precautions to ensure safe use.

- Assess renal function: adjust therapy in patients with severe renal impairment. - Monitor magnesium levels: prolonged treatment may cause hypomagnesemia. - Review concomitant medications: avoid use with drugs that have major interactions. - Use with caution in the elderly: increased risk of fractures and infections. - Store at room temperature: keep in the original container, protect from moisture and heat.

Lansoprazole can affect the pharmacokinetics of several medicines; awareness of these interactions helps prevent therapeutic failures or toxicity.

Major Interactions (Avoid): - Ketoconazole: reduced absorption and efficacy of ketoconazole. - Atazanavir: decreased plasma concentrations of atazanavir. - Clopidogrel: diminished activation leading to reduced antiplatelet effect. - Warfarin: possible increase in INR and bleeding risk.

Moderate Interactions (Monitor Closely): - Digoxin: may raise serum digoxin levels. - Methotrexate: increased risk of toxicity with high‑dose regimens. - Phenytoin: decreased phenytoin concentrations.